Yield Theory

Stock research

Eli Lilly and Company LLY

Eli Lilly is a pharmaceutical company whose GLP-1 diabetes and obesity treatments have become blockbuster franchises. It also develops therapies in oncology, immunology, and neuroscience.
Loading delayed market data…

Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.

Ticker
LLY
Exchange
NYSE
Sector
Health
Founded
1876

What moves LLY

Eli Lilly and Company sits in Health Care. Pharmaceuticals, biotech, medical devices, and managed care — defensive demand paired with binary drug and regulatory catalysts. The forces that matter most for the sector — and therefore for LLY — are:

  • Drug approvals and clinical-trial readouts
  • Medicare and drug-pricing policy
  • Demographics and an aging population
  • GLP-1 and obesity-drug demand

Congressional trading in LLY

No matched LLY transaction appears in the current verified House Clerk snapshot. We do not turn a missing row into a claim that no member has ever traded the security.

Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.

The profile is free

LLY research stays free. Membership is the living thesis: what we believe, what we’re watching, and when conviction should end.

Get this month’s call for $15

How Yield Theory covers LLY

LLY intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.

US markets

LLY — frequently asked questions

What sector is LLY in?

Eli Lilly and Company is classified in the Health Care sector and trades on the NYSE.

Do members of Congress trade LLY?

The current verified House Clerk snapshot contains no matched LLY transaction rows. That is not proof that no lawmaker has ever traded the security.

Is LLY a good investment?

We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.

Where is Eli Lilly and Company headquartered?

Eli Lilly and Company is headquartered in Indianapolis, Indiana and was founded in 1876.

This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.

See whether the LLY thesis still holds.

This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included